NORTH CHICAGO, Ill., May 13, 2015 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the UBS Global Healthcare Conference on Wednesday, May 20, 2015. Bill Chase, executive vice president and chief financial officer, will participate in a question and answer session at 9 a.m. Central time.

A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations Web site at www.abbvieinvestor.com.  An archived edition of the session will be available later that day.

About AbbVie
AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. AbbVie employs more than 26,000 people worldwide and markets medicines in more than 170 countries. For further information on the company and its people, portfolio and commitments, please visit www.abbvie.com. Follow @abbvie on Twitter or view careers on our Facebook or LinkedIn page.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/abbvie-to-present-at-ubs-global-healthcare-conference-300082243.html

SOURCE AbbVie

Media, Adelle Infante, (847) 938-8745; or Investors, Liz Shea, (847) 935-2211